Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity

Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.

6,726 public trials 634 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity trial results

Active, Not Recruiting

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

NCT07217015

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Kymera Investigative Site Birmingham, Alabama, United States
  • Kymera Investigative Site North Little Rock, Arkansas, United States
  • Kymera Investigative Site Freemont, California, United States
  • Kymera Investigative Site Los Angeles, California, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks

NCT06851559

Conditions
Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +10 more
Locations
  • Preferred Research Partners, Inc Little Rock, Arkansas, United States
  • GW Research, Inc Chula Vista, California, United States
  • Southern California Research Institute Medical Group Los Angeles, California, United States
  • Rocky Mountain Gastroenterology Lakewood, Colorado, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

NCT05729711

Conditions
Asthma, Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy), Bronchial Diseases, +7 more
Locations
  • Research Site Aichi, Japan
  • Research Site Akita, Japan
  • Research Site Aomori, Japan
  • Research Site Chiba, Japan
View all 33 locations
View Trial Details
Active, Not Recruiting

Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy

NCT06369467

Conditions
Food Allergy, Food Hypersensitivity, Hypersensitivity, +3 more
Locations
  • University of South Florida Tampa, Florida, United States
  • Emory University - Winship Cancer Institute Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Active, Not Recruiting

Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)

NCT06940141

Conditions
Asthma, Asthma Acute, Bronchial Diseases, +7 more
Locations
  • Leland Stanford Junior University, Stanford Hospital Palo Alto, California, United States
  • Amicis Research Center Valencia, California, United States
  • Nemours Children's Hospital - DE Wilmington, Delaware, United States
  • Nemours Children's Health Jacksonville, Florida, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT04137562

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Chungnam National University Hospital Daejeon, Chungcheongnam-do, South Korea
  • Korea University AnSan Hospital Ansan, Gyeonggi-do, South Korea
  • Chung-Ang University Hospital Seoul, Seoulteukbyeolsi, South Korea
  • Kyunghee University Medical Center Seoul, Seoulteukbyeolsi, South Korea
View Trial Details

Related conditions